isopropyl alcohol + dexamethasone sodium phosphate + bupivacaine hydrochloride + triamcinolone

This entry appears to describe a **multi-ingredient compounded injection mixture** containing isopropyl alcohol, dexamethasone sodium phosphate, bupivacaine hydrochloride, and triamcinolone. The recognizable pharmacologically active therapeutic components are the corticosteroids dexamethasone sodium phosphate and triamcinolone, which provide anti-inflammatory and immunosuppressive effects primarily through activation of the glucocorticoid receptor, together with bupivacaine hydrochloride, a local anesthetic that blocks voltage-gated sodium channels to provide analgesia. Isopropyl alcohol is not a standard therapeutic active ingredient in approved injectable drug products and more plausibly reflects a procedural antiseptic or data-entry artifact rather than a true co-formulated active pharmaceutical ingredient. Based on the provided context, the name does **not** map cleanly to a single recognized marketed or pipeline drug asset, and the indication list supplied appears to correspond broadly to systemic and local corticosteroid labeling rather than to this exact four-component combination.

Other names

isopropyl alcohol + dexamethasone sodium phosphate + bupivacaine hydrochloride + triamcinolone